Private Life Sciences Company Completes $1M Private Placement

A private life sciences company, which manufactures a painless microneedle injection device used for insulin, completed a $1 million private placement of common stock and warrants. Our firm represented the life sciences company in the private placement.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.